Research Use Only. This compound is not intended for human consumption or therapeutic use.
Where to Buy LGD4033: Vendor Comparison & Research Info
LGD-4033 (Ligandrol) is an experimental selective androgen receptor modulator studied for its effects on androgen receptor signaling, skeletal muscle biology, bone metabolism, and endocrine pathways. Originally investigated in muscle-wasting research, LGD-4033 remains a preclinical research compound with ongoing interest in androgen-responsive tissue studies.
What is LGD4033?
Overview
LGD-4033, commonly known as Ligandrol, is an experimental non-steroidal selective androgen receptor modulator (SARM) investigated for its interaction with androgen receptors in tissues such as skeletal muscle and bone.
Originally developed as a potential research candidate for conditions involving muscle wasting and loss of lean tissue, LGD-4033 has been studied for its effects on androgen-receptor signaling, muscle-related gene expression, and endocrine regulation.
Unlike traditional anabolic-androgenic steroids, LGD-4033 was designed to investigate more selective androgen receptor activity. However, its tissue selectivity does not mean that systemic endocrine effects are absent.
Research Profile
LGD-4033 has attracted research interest because of its strong affinity for the androgen receptor and its potential to influence androgen-responsive tissues.
Research areas include:
Skeletal muscle biology
Androgen receptor signaling
Bone metabolism
Protein synthesis pathways
Muscle-wasting models
Endocrine and hormonal regulation
Mechanism of Action
LGD-4033 binds to the androgen receptor (AR) and can influence receptor-mediated gene transcription. Following receptor activation, the AR complex can interact with androgen response elements involved in regulating genes associated with muscle and bone physiology.
Experimental research has examined LGD-4033 in relation to lean tissue development, muscle protein metabolism, and androgen-dependent cellular signaling.
Importantly, androgen receptor modulation can also influence the hypothalamic-pituitary-gonadal (HPG) axis. Research has therefore evaluated changes in circulating hormones and gonadotropins following LGD-4033 exposure.
Research Applications
1. Skeletal Muscle Research
LGD-4033 provides an experimental model for studying androgen receptor signaling in skeletal muscle and pathways associated with muscle protein metabolism.
2. Muscle-Wasting Research
Because of its anabolic activity in preclinical research, LGD-4033 has been investigated as a potential research tool for understanding mechanisms involved in muscle loss and preservation of lean tissue.
3. Bone Biology
Androgen receptors are present in bone-related cells, making LGD-4033 relevant to studies examining androgen signaling and bone metabolism.
4. Endocrine Research
Controlled studies have examined LGD-4033's effects on testosterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH), providing a model for investigating the relationship between selective androgen receptor activation and hormonal feedback.
Pharmacological Research Considerations
LGD-4033 has demonstrated androgen receptor activity in experimental studies, but its selectivity should not be interpreted as an absence of adverse systemic effects.
Human research has reported measurable changes in hormonal and lipid parameters, highlighting the importance of distinguishing tissue selectivity from complete safety.
LGD-4033 is not an approved treatment for muscle wasting, athletic performance, bodybuilding, or any other medical indication.
Quality & Analytical Testing
For research applications, compound identity and purity should be established using validated analytical techniques. Depending on the laboratory and supplier, characterization may include HPLC, mass spectrometry, and other analytical methods.
Researchers should consult the applicable batch-specific Certificate of Analysis (CoA) for verified information regarding purity, identity, and analytical results.
Safety Information
LGD-4033 remains an experimental compound and is not approved for general human use. Research has identified potential concerns involving hormonal suppression, changes in lipid parameters, liver enzymes, and other androgen-related effects.
The long-term safety profile of LGD-4033 has not been adequately established, and findings from controlled research should not be interpreted as evidence that the compound is suitable for self-administration.
Research-Only Statement
LGD-4033 is intended strictly for laboratory research and analytical purposes. It is not intended for human or veterinary consumption, self-administration, diagnosis, treatment, or prevention of any disease or medical condition.
Where to Buy LGD4033 Online
| Rank | Vendor | Trust Score | Vial Size | Price / mg | Status | Action |
|---|---|---|---|---|---|---|
1 | ![]() Dragon Pharma Store Verified | 9.0/10 Editorial Rating | $90.00 15mg vial | $6.00/mg | In Stock | Visit Site |
Top-Ranked Vendor

Dragon Pharma is a global supplier of performance-enhancing compounds, offering a wide range of pharmaceutical-grade anabolic steroids, hormones, and post-cycle therapy (PCT) products designed to support muscle growth, strength, and recovery.
Chemical Properties & Handling
Standard storage protocols for lyophilized peptides generally apply unless otherwise specified.
- Lyophilized (Powder): Store at -20°C for up to 3 years. Keep away from direct light and moisture.
- Reconstituted (Liquid): Store at 2-8°C (refrigerated) and use within 20-30 days to maintain stability.
Research Reviews
No Research Reviews Yet
Be the first to share your research protocol and vendor experience with LGD4033.